Alkermes plc (ALKS)
USD 27.54
(2.0%)
USD 27.54
(2.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 290.73 Million USD | -0.87% |
| 2022 | 293.27 Million USD | -0.86% |
| 2021 | 295.8 Million USD | 7.58% |
| 2020 | 274.96 Million USD | -0.79% |
| 2019 | 277.13 Million USD | -0.78% |
| 2018 | 279.3 Million USD | -0.76% |
| 2017 | 281.43 Million USD | -0.79% |
| 2016 | 283.66 Million USD | -18.94% |
| 2015 | 349.94 Million USD | -2.24% |
| 2014 | 357.97 Million USD | -2.99% |
| 2013 | 369 Million USD | -16.98% |
| 2012 | 444.46 Million USD | 0.0% |
| 2011 | 444.46 Million USD | 770.76% |
| 2010 | 51.04 Million USD | -32.74% |
| 2009 | 75.88 Million USD | -52.68% |
| 2008 | 160.37 Million USD | 1.2% |
| 2007 | 158.47 Million USD | -43.68% |
| 2006 | 281.4 Million USD | 1.27% |
| 2005 | 277.87 Million USD | 118.26% |
| 2004 | 127.31 Million USD | -26.99% |
| 2003 | 174.38 Million USD | -21.39% |
| 2002 | 221.82 Million USD | -0.43% |
| 2001 | 222.79 Million USD | -2.46% |
| 2000 | 228.41 Million USD | 483.94% |
| 1999 | 39.11 Million USD | 129.59% |
| 1998 | 17.03 Million USD | 17.81% |
| 1997 | 14.46 Million USD | 12.98% |
| 1996 | 12.8 Million USD | 15.32% |
| 1995 | 11.1 Million USD | 23.33% |
| 1994 | 9 Million USD | 210.34% |
| 1993 | 2.9 Million USD | 866.67% |
| 1992 | 300 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 370.1 Million USD | 27.3% |
| 2024 Q3 | 288.82 Million USD | -0.54% |
| 2024 Q2 | 368 Million USD | -0.57% |
| 2023 Q3 | 291.36 Million USD | -0.22% |
| 2023 Q2 | 292 Million USD | -0.22% |
| 2023 Q4 | 290.73 Million USD | -0.22% |
| 2023 Q1 | 292.63 Million USD | -0.22% |
| 2023 FY | 290.73 Million USD | -0.87% |
| 2022 Q1 | 415.32 Million USD | 40.41% |
| 2022 Q2 | 410.31 Million USD | -1.21% |
| 2022 Q3 | 405.39 Million USD | -1.2% |
| 2022 Q4 | 293.27 Million USD | -27.66% |
| 2022 FY | 293.27 Million USD | -0.86% |
| 2021 FY | 295.8 Million USD | 7.58% |
| 2021 Q3 | 296.43 Million USD | -30.18% |
| 2021 Q2 | 424.58 Million USD | -1.04% |
| 2021 Q4 | 295.8 Million USD | -0.21% |
| 2021 Q1 | 429.03 Million USD | 56.04% |
| 2020 Q2 | 390.78 Million USD | -0.87% |
| 2020 Q4 | 274.96 Million USD | -28.69% |
| 2020 FY | 274.96 Million USD | -0.79% |
| 2020 Q1 | 394.19 Million USD | 42.24% |
| 2020 Q3 | 385.59 Million USD | -1.33% |
| 2019 Q1 | 278.76 Million USD | -0.19% |
| 2019 Q4 | 277.13 Million USD | -5.4% |
| 2019 Q3 | 292.96 Million USD | -0.96% |
| 2019 Q2 | 295.79 Million USD | 6.11% |
| 2019 FY | 277.13 Million USD | -0.78% |
| 2018 Q1 | 280.93 Million USD | -0.18% |
| 2018 Q4 | 279.3 Million USD | -0.19% |
| 2018 Q3 | 279.85 Million USD | -0.19% |
| 2018 Q2 | 280.39 Million USD | -0.19% |
| 2018 FY | 279.3 Million USD | -0.76% |
| 2017 FY | 281.43 Million USD | -0.79% |
| 2017 Q4 | 281.43 Million USD | -0.2% |
| 2017 Q3 | 281.99 Million USD | -0.2% |
| 2017 Q2 | 282.55 Million USD | -0.2% |
| 2017 Q1 | 283.1 Million USD | -0.2% |
| 2016 FY | 283.66 Million USD | -18.94% |
| 2016 Q4 | 283.66 Million USD | -0.67% |
| 2016 Q1 | 348.48 Million USD | -0.42% |
| 2016 Q2 | 347.03 Million USD | -0.42% |
| 2016 Q3 | 285.57 Million USD | -17.71% |
| 2015 Q3 | 353.22 Million USD | -0.45% |
| 2015 Q2 | 354.8 Million USD | -0.44% |
| 2015 Q4 | 349.94 Million USD | -0.93% |
| 2015 FY | 349.94 Million USD | -2.24% |
| 2015 Q1 | 356.38 Million USD | -0.44% |
| 2014 Q3 | 359.55 Million USD | -0.44% |
| 2014 Q2 | 361.13 Million USD | -0.44% |
| 2014 Q1 | 362.71 Million USD | -0.51% |
| 2014 FY | 357.97 Million USD | -2.99% |
| 2014 Q4 | 357.97 Million USD | -0.44% |
| 2013 Q1 | 369 Million USD | -0.02% |
| 2013 Q4 | 364.56 Million USD | -0.36% |
| 2013 Q3 | 365.87 Million USD | -0.43% |
| 2013 Q2 | 367.44 Million USD | -0.42% |
| 2013 FY | 369 Million USD | -16.98% |
| 2012 FY | 444.46 Million USD | 0.0% |
| 2012 Q1 | 444.46 Million USD | -0.07% |
| 2012 Q2 | 444.18 Million USD | -0.06% |
| 2012 Q3 | 370.59 Million USD | -16.57% |
| 2012 Q4 | 369.09 Million USD | -0.4% |
| 2011 Q4 | 444.76 Million USD | 0.13% |
| 2011 FY | 444.46 Million USD | 770.76% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | 444.18 Million USD | 0.0% |
| 2010 Q1 | 51.04 Million USD | -10.92% |
| 2010 FY | 51.04 Million USD | -32.74% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | -100.0% |
| 2010 Q2 | 44.75 Million USD | -12.33% |
| 2009 Q1 | 75.88 Million USD | -17.91% |
| 2009 Q2 | 69.72 Million USD | -8.12% |
| 2009 Q3 | 63.52 Million USD | -8.89% |
| 2009 FY | 75.88 Million USD | -52.68% |
| 2009 Q4 | 57.3 Million USD | -9.8% |
| 2008 Q1 | 160.37 Million USD | 0.18% |
| 2008 Q3 | 91.88 Million USD | -37.61% |
| 2008 Q4 | 92.44 Million USD | 0.6% |
| 2008 FY | 160.37 Million USD | 1.2% |
| 2008 Q2 | 147.29 Million USD | -8.16% |
| 2007 Q3 | 159.53 Million USD | 0.33% |
| 2007 FY | 158.47 Million USD | -43.68% |
| 2007 Q1 | 158.47 Million USD | -0.09% |
| 2007 Q4 | 160.08 Million USD | 0.34% |
| 2007 Q2 | 159.01 Million USD | 0.34% |
| 2006 Q3 | 158.03 Million USD | 0.32% |
| 2006 Q1 | 281.4 Million USD | -7.39% |
| 2006 Q2 | 157.54 Million USD | -44.02% |
| 2006 FY | 281.4 Million USD | 1.27% |
| 2006 Q4 | 158.61 Million USD | 0.37% |
| 2005 FY | 277.87 Million USD | 118.26% |
| 2005 Q2 | 278.21 Million USD | 0.12% |
| 2005 Q1 | 277.87 Million USD | 115.12% |
| 2005 Q3 | 278.87 Million USD | 0.24% |
| 2005 Q4 | 303.85 Million USD | 8.96% |
| 2004 Q1 | 127.31 Million USD | 3.94% |
| 2004 Q2 | 125.97 Million USD | -1.06% |
| 2004 Q3 | 124.97 Million USD | -0.79% |
| 2004 Q4 | 129.17 Million USD | 3.36% |
| 2004 FY | 127.31 Million USD | -26.99% |
| 2003 Q2 | 173.63 Million USD | -0.43% |
| 2003 Q4 | 122.48 Million USD | 0.14% |
| 2003 Q3 | 122.31 Million USD | -29.56% |
| 2003 Q1 | 174.38 Million USD | -0.37% |
| 2003 FY | 174.38 Million USD | -21.39% |
| 2002 Q4 | 175.04 Million USD | 1695.28% |
| 2002 Q3 | 9.75 Million USD | -95.37% |
| 2002 Q2 | 210.72 Million USD | -5.0% |
| 2002 Q1 | 221.82 Million USD | -6.77% |
| 2002 FY | 221.82 Million USD | -0.43% |
| 2001 FY | 222.79 Million USD | -2.46% |
| 2001 Q1 | 222.79 Million USD | -0.6% |
| 2001 Q4 | 237.92 Million USD | 8.1% |
| 2001 Q3 | 220.09 Million USD | 926.47% |
| 2001 Q2 | 21.44 Million USD | -90.38% |
| 2000 Q4 | 224.14 Million USD | -0.63% |
| 2000 FY | 228.41 Million USD | 483.94% |
| 2000 Q3 | 225.56 Million USD | -0.63% |
| 2000 Q1 | 228.41 Million USD | 577.46% |
| 2000 Q2 | 226.99 Million USD | -0.62% |
| 1999 FY | 39.11 Million USD | 129.59% |
| 1999 Q2 | 37.31 Million USD | -4.6% |
| 1999 Q3 | 35.51 Million USD | -4.82% |
| 1999 Q1 | 39.11 Million USD | 2.48% |
| 1999 Q4 | 33.71 Million USD | -5.07% |
| 1998 FY | 17.03 Million USD | 17.81% |
| 1998 Q1 | 17.03 Million USD | 22.86% |
| 1998 Q3 | 30.32 Million USD | 87.12% |
| 1998 Q4 | 38.16 Million USD | 25.84% |
| 1998 Q2 | 16.2 Million USD | -4.87% |
| 1997 Q4 | 13.86 Million USD | -6.8% |
| 1997 FY | 14.46 Million USD | 12.98% |
| 1997 Q1 | 14.46 Million USD | -6.39% |
| 1997 Q2 | 15.98 Million USD | 10.52% |
| 1997 Q3 | 14.87 Million USD | -6.91% |
| 1996 FY | 12.8 Million USD | 15.32% |
| 1996 Q2 | 12.07 Million USD | -5.68% |
| 1996 Q3 | 16.34 Million USD | 35.37% |
| 1996 Q1 | 12.8 Million USD | -11.11% |
| 1996 Q4 | 15.44 Million USD | -5.46% |
| 1995 Q1 | 11.1 Million USD | 35.37% |
| 1995 FY | 11.1 Million USD | 23.33% |
| 1995 Q3 | 9.7 Million USD | -5.83% |
| 1995 Q4 | 14.4 Million USD | 48.45% |
| 1995 Q2 | 10.3 Million USD | -7.21% |
| 1994 Q1 | 9 Million USD | -2.17% |
| 1994 Q2 | 8.4 Million USD | -6.67% |
| 1994 Q3 | 7.8 Million USD | -7.14% |
| 1994 Q4 | 8.2 Million USD | 5.13% |
| 1994 FY | 9 Million USD | 210.34% |
| 1993 Q2 | 2.8 Million USD | -3.45% |
| 1993 Q4 | 9.2 Million USD | 253.85% |
| 1993 Q1 | 2.9 Million USD | 16.0% |
| 1993 Q3 | 2.6 Million USD | -7.14% |
| 1993 FY | 2.9 Million USD | 866.67% |
| 1992 Q3 | 300 Thousand USD | 0.0% |
| 1992 FY | 300 Thousand USD | 0.0% |
| 1992 Q2 | 300 Thousand USD | 0.0% |
| 1992 Q1 | 300 Thousand USD | 0.0% |
| 1992 Q4 | 2.5 Million USD | 733.33% |
| 1991 Q3 | 400 Thousand USD | 0.0% |
| 1991 Q2 | 400 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | 16.993% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1912.808% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -957.777% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -148.078% |
| MiMedx Group, Inc. | 48.09 Million USD | -504.441% |
| Novavax, Inc. | 280.63 Million USD | -3.597% |
| Seer, Inc. | 28.25 Million USD | -928.805% |
| Acelyrin, Inc. | 1.19 Million USD | -24249.246% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -26.851% |
| IO Biotech, Inc. | 2.49 Million USD | -11557.177% |
| Ardelyx, Inc. | 55.98 Million USD | -419.328% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -309.617% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1292.103% |
| Fortress Biotech, Inc. | 88.59 Million USD | -228.167% |
| Fortress Biotech, Inc. | 88.59 Million USD | -228.167% |
| Geron Corporation | 85.89 Million USD | -238.456% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -152.433% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -4332.535% |
| Incyte Corporation | 38.28 Million USD | -659.344% |
| Innoviva, Inc. | 449.07 Million USD | 35.26% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -8771.834% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -4615.815% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -4301.665% |
| Onconetix, Inc. | 9.88 Million USD | -2840.893% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -91324.528% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -35863.543% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -10022.911% |
| Vaxcyte, Inc. | 29.22 Million USD | -894.833% |
| Precigen, Inc. | 7.09 Million USD | -3996.52% |
| Pharming Group N.V. | 171.54 Million USD | -69.477% |
| ContextLogic Inc. | 6 Million USD | -4745.5% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -29934.091% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1262.946% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -379.919% |
| AlloVir, Inc. | 27.42 Million USD | -959.937% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -163.443% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -100275.29% |
| Summit Therapeutics Inc. | 106.09 Million USD | -174.018% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -17681.651% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -4583.151% |
| Senti Biosciences, Inc. | 37.66 Million USD | -671.863% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -186.761% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -326.103% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -3696.721% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -717.685% |
| Chimerix, Inc. | 2.14 Million USD | -13460.168% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1118.911% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1627.451% |
| CRISPR Therapeutics AG | 238.63 Million USD | -21.832% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -805.193% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -109.113% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -918.64% |
| Precision BioSciences, Inc. | 31.26 Million USD | -829.8% |
| Dyadic International, Inc. | 136.92 Thousand USD | -212221.714% |
| Elevation Oncology, Inc. | 30.13 Million USD | -864.695% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -5229.606% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -179.06% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 89.162% |
| Aptorum Group Limited | 3.36 Million USD | -8546.51% |
| Bicycle Therapeutics plc | 44.95 Million USD | -546.699% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -287751.485% |
| Clearside Biomedical, Inc. | 43 Million USD | -576.101% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -46640.932% |
| GT Biopharma, Inc. | 58 Thousand USD | -501158.621% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -538.827% |
| Jaguar Health, Inc. | 35.86 Million USD | -710.736% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -13613.679% |
| AbCellera Biologics Inc. | 77.38 Million USD | -275.717% |
| PureTech Health plc | 25.51 Million USD | -1039.581% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -64424.792% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -662.991% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -31989.404% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2140.521% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -4039.095% |
| AnaptysBio, Inc. | 17.81 Million USD | -1532.031% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1395.14% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -361828.593% |
| Molecular Templates, Inc. | 12.23 Million USD | -2277.187% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -116.15% |
| Vaxxinity, Inc. | 15.16 Million USD | -1816.733% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1037.619% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -17488.022% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1084.622% |
| Structure Therapeutics Inc. | 5.45 Million USD | -5231.56% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -61106.316% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -4153.548% |
| ImmuCell Corporation | 11.96 Million USD | -2328.963% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -123894.012% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -135755.14% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -44.909% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2850.974% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -368.353% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -180.801% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -38.35% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -8073.461% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -17133.551% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -96579.902% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1060.97% |
| Aptose Biosciences Inc. | 1 Million USD | -28690.679% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -3358610.721% |
| Soligenix, Inc. | 3.49 Million USD | -8219.5% |
| Century Therapeutics, Inc. | 48.17 Million USD | -503.537% |
| Kura Oncology, Inc. | 17.2 Million USD | -1590.291% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -214.531% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -183906.329% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -13422.326% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1980.507% |
| Autolus Therapeutics plc | 52.96 Million USD | -448.889% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -5215.963% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -594.812% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -26.717% |
| GRI Bio, Inc. | 14 Thousand USD | -2076542.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2240.068% |
| IGM Biosciences, Inc. | 40.5 Million USD | -617.746% |
| INmune Bio, Inc. | 10.43 Million USD | -2685.571% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -61.851% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -4821.739% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -355837.806% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -35061.409% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -461.526% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -398.842% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -402.367% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 39.537% |
| Verastem, Inc. | 41.55 Million USD | -599.593% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -5283.889% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2456.542% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2862.703% |
| Histogen Inc. | 4.62 Million USD | -6190.134% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -8504.025% |
| Organovo Holdings, Inc. | 1.39 Million USD | -20755.811% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -531.998% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -5497.42% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1268.85% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1361633.021% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -243.701% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -138991.953% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -862.172% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -179012.477% |
| Apollomics, Inc. | 4.66 Million USD | -6137.503% |
| Amarin Corporation plc | 8.73 Million USD | -3227.572% |
| Mesoblast Limited | 118.92 Million USD | -144.469% |
| Turnstone Biologics Corp. | 3.21 Million USD | -8945.737% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -243.352% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -117604.453% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -197.858% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -53.061% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1853.831% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -849.664% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -162.089% |
| NLS Pharmaceutics AG | 1.63 Million USD | -17695.3% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -4642.741% |
| Gritstone bio, Inc. | 104.77 Million USD | -177.48% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -10335.391% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -594804.85% |
| Avid Bioservices, Inc. | 207.83 Million USD | -39.886% |
| Insmed Incorporated | 1.2 Billion USD | 75.853% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -4232.141% |
| OmniAb, Inc. | 25.56 Million USD | -1037.397% |
| Alector, Inc. | 38.91 Million USD | -647.032% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -35.896% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -1818.883% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 39.233% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1386.578% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -360.256% |
| Immunic, Inc. | 1.33 Million USD | -21693.853% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -816.204% |
| Veracyte, Inc. | 12.63 Million USD | -2201.9% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 54.916% |
| FibroGen, Inc. | 170.45 Million USD | -70.561% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3101.52% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -142476.909% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 94.985% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -785656.757% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -6761.695% |
| TG Therapeutics, Inc. | 110.79 Million USD | -162.404% |
| Galecto, Inc. | 249 Thousand USD | -116659.036% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -17350.78% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 82.674% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -3873.35% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5286.882% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -10335.391% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -981.545% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -545.02% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -20388.372% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -542.696% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -573.469% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -502.812% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 65.745% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -28197.7% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2553.857% |
| NexImmune, Inc. | 68.8 Thousand USD | -422417.403% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2048159.828% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 89.244% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -74065.438% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -4109.818% |
| Ainos, Inc. | 5.96 Million USD | -4775.111% |
| Pluri Inc. | 29.61 Million USD | -881.798% |
| Prothena Corporation plc | 11.83 Million USD | -2356.527% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1052.09% |
| Celularity Inc. | 65.41 Million USD | -344.426% |
| Rallybio Corporation | 392 Thousand USD | -74065.816% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1878.428% |
| MeiraGTx Holdings plc | 89.26 Million USD | -225.697% |
| Omeros Corporation | 338.28 Million USD | 14.057% |
| Humacyte, Inc. | 58.1 Million USD | -400.344% |
| Immunocore Holdings plc | 84.03 Million USD | -245.975% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -15589.692% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -5861.247% |
| Blueprint Medicines Corporation | 774.12 Million USD | 62.444% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -5693.743% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -370.3% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -179.29% |
| Pulmatrix, Inc. | 8.75 Million USD | -3220.352% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -4103.123% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1999.134% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -152.05% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -821.548% |
| Cytokinetics, Incorporated | 755.77 Million USD | 61.532% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2072.221% |
| Nutriband Inc. | 241.28 Thousand USD | -120392.364% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -5217.907% |
| Vor Biopharma Inc. | 35.66 Million USD | -715.283% |
| Roivant Sciences Ltd. | 499.74 Million USD | 41.825% |
| Evogene Ltd. | 1.13 Million USD | -25447.452% |
| ProKidney Corp. | 4.41 Million USD | -6488.035% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -23613.703% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -526918.943% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 83.29% |
| CorMedix Inc. | 667.63 Thousand USD | -43446.445% |
| BioLineRx Ltd. | 11.59 Million USD | -2408.239% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -646.994% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -304.877% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1664.567% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -11761.708% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -42971.111% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -535.156% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -447176.923% |
| MediciNova, Inc. | 215.92 Thousand USD | -134543.35% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -11552.505% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -22955.0% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -55.994% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2723.718% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 29.949% |
| Mereo BioPharma Group plc | 5.95 Million USD | -4784.577% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -7998.329% |
| Absci Corporation | 15.95 Million USD | -1721.959% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3073.562% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1881.665% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -960.478% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2271.757% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2224.724% |
| Allakos Inc. | 41.46 Million USD | -601.146% |
| Imunon, Inc. | 1.62 Million USD | -17794.226% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2586.72% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -192436.424% |
| BioAtla, Inc. | 2.46 Million USD | -11718.293% |
| NLS Pharmaceutics AG | 1.63 Million USD | -17695.3% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -257183.186% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -205.642% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -5142.157% |
| XOMA Corporation | 124.45 Million USD | -133.612% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1435.573% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -573.501% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1826.002% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2510.253% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1016.346% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1281.271% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -83203.725% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -88946.32% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -17717.341% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 80.608% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -177210.068% |
| UroGen Pharma Ltd. | 100.21 Million USD | -190.109% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -59.087% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -83843.039% |
| Orgenesis Inc. | 22.62 Million USD | -1185.222% |
| Entera Bio Ltd. | 390 Thousand USD | -74446.154% |
| GH Research PLC | 343 Thousand USD | -84660.933% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -95221.311% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -29779.753% |
| Xencor, Inc. | 83.43 Million USD | -248.455% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -168270.272% |
| Replimune Group, Inc. | 75.86 Million USD | -283.2% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -23648.066% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2991.557% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -177210.068% |
| Portage Biotech Inc. | 47 Thousand USD | -618474.468% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -22955.0% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -11928.548% |
| OncoCyte Corporation | 2.86 Million USD | -10033.496% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -22277.341% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -193006.792% |
| Purple Biotech Ltd. | 351 Thousand USD | -82729.06% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -9103.229% |
| scPharmaceuticals Inc. | 40.26 Million USD | -621.97% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -467.91% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -204639.437% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -5457.828% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -987.329% |
| Curis, Inc. | 2.79 Million USD | -10305.512% |
| Daré Bioscience, Inc. | 5.31 Million USD | -5366.756% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -13508.095% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -51356.637% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1637.673% |
| BeiGene, Ltd. | 930.18 Million USD | 68.745% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1770.548% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -230.585% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -25380.28% |
| Erasca, Inc. | 55.85 Million USD | -420.471% |
| bluebird bio, Inc. | 330.32 Million USD | 11.987% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 74.36% |
| DBV Technologies S.A. | 14.38 Million USD | -1921.626% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -11519.904% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -6160.336% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 28.177% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -531.486% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -6207.876% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -11337.057% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1442.089% |
| MacroGenics, Inc. | 33.97 Million USD | -755.818% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1289.457% |
| Prime Medicine, Inc. | 13.63 Million USD | -2032.546% |
| Aditxt, Inc. | 18.21 Million USD | -1495.84% |
| Adagene Inc. | 22.3 Million USD | -1203.32% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1799.824% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 52.415% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1332.662% |
| SciSparc Ltd. | 76 Thousand USD | -382439.474% |
| Vericel Corporation | 88.14 Million USD | -229.839% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -254.476% |
| Generation Bio Co. | 97.89 Million USD | -196.984% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -88267.781% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1049.221% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -41.189% |
| Invivyd, Inc. | 2.16 Million USD | -13328.637% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -443.766% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -8250532.143% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -5144.994% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -461376.19% |
| 2seventy bio, Inc. | 256.67 Million USD | -13.269% |
| ADMA Biologics, Inc. | 141.41 Million USD | -105.582% |
| Clene Inc. | 32.16 Million USD | -803.983% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -5080.364% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -13145.103% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -473.749% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -60312.056% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -50.488% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -865.047% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1590.586% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -133.443% |
| Evaxion Biotech A/S | 10.86 Million USD | -2574.688% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -248.643% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -288.121% |
| Trevena, Inc. | 35.23 Million USD | -725.164% |
| Surrozen, Inc. | 3.37 Million USD | -8504.025% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -4375.523% |
| Cingulate Inc. | 3.13 Million USD | -9173.391% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -708997.561% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -977.177% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -57941.178% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -48113.93% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -408.225% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -62422.581% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -928.332% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1337.905% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -18596.463% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -22973.81% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1687.882% |
| ImmunityBio, Inc. | 883.67 Million USD | 67.1% |
| Korro Bio, Inc. | 33.2 Million USD | -775.508% |
| Kineta, Inc. | 1.31 Million USD | -21975.171% |
| BioVie Inc. | 6.11 Million USD | -4657.139% |
| Codexis, Inc. | 22.36 Million USD | -1199.991% |
| Celularity Inc. | 65.41 Million USD | -344.426% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -462.036% |
| Celcuity Inc. | 37.44 Million USD | -676.392% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -129516.585% |
| Cibus, Inc. | 24.62 Million USD | -1080.821% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -75808.616% |
| IN8bio, Inc. | 4.89 Million USD | -5841.754% |
| Kodiak Sciences Inc. | 181.63 Million USD | -60.065% |
| Annexon, Inc. | 31.35 Million USD | -827.221% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -287.454% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -12313.749% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -7348.885% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 79.998% |
| Eyenovia, Inc. | 16.1 Million USD | -1704.907% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -160.768% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -29415.736% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2437.575% |
| Arcellx, Inc. | 97.62 Million USD | -197.803% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -13428.618% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -996.556% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -9272.34% |
| Moolec Science SA | 2.64 Million USD | -10890.482% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -920.571% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -4505.259% |
| Royalty Pharma plc | 6.13 Billion USD | 95.261% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -12003.664% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -252151.549% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -759.385% |
| Humacyte, Inc. | 58.1 Million USD | -400.344% |
| 89bio, Inc. | 27.1 Million USD | -972.488% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2088.243% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -11441.485% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -21628.7% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -174.108% |
| Notable Labs, Ltd. | 2.04 Million USD | -14088.873% |
| Liquidia Corporation | 3.5 Million USD | -8199.458% |
| Mustang Bio, Inc. | 2.49 Million USD | -11538.511% |
| Immunovant, Inc. | 138 Thousand USD | -210573.913% |
| Quantum-Si incorporated | 15.3 Million USD | -1799.824% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3233.677% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -72582.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -441.316% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -355837.806% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2566.514% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -138021.232% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -143116.749% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1307.144% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -72041.439% |
| PepGen Inc. | 20.1 Million USD | -1346.13% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -50549.826% |
| United Therapeutics Corporation | 700 Million USD | 58.467% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1006.91% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -6414.288% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -32713.77% |
| XOMA Corporation | 124.45 Million USD | -133.612% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -106005.839% |
| Bionomics Limited | 239.61 Million USD | -21.331% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -14193.517% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2089.892% |
| uniQure N.V. | 138.4 Million USD | -110.051% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -240.342% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -28071.512% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -29415.736% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3101.52% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -16541.671% |
| Altimmune, Inc. | 671 Thousand USD | -43227.869% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 34.676% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2089.892% |
| Compugen Ltd. | 1.35 Million USD | -21419.615% |
| Peak Bio, Inc. | 10.72 Million USD | -2611.577% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -579.816% |
| Benitec Biopharma Inc. | 284 Thousand USD | -102269.718% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -243.835% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1359.415% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -2368.206% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -217.884% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1359.415% |
| Instil Bio, Inc. | 86.05 Million USD | -237.846% |
| argenx SE | 20 Million USD | -1353.65% |
| Immunome, Inc. | 1.65 Million USD | -17520.0% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -16676.111% |
| Verona Pharma plc | 51.32 Million USD | -466.405% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2873.307% |
| Shattuck Labs, Inc. | 4.2 Million USD | -6818.848% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -80212.155% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -6853.6% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -49597.436% |
| Moolec Science SA | 2.64 Million USD | -10890.482% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -862.388% |
| Design Therapeutics, Inc. | 3.05 Million USD | -9432.131% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -110865.649% |
| NeurAxis, Inc. | 224.26 Thousand USD | -129539.704% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1943.365% |
| Lumos Pharma, Inc. | 6.58 Million USD | -4315.034% |
| Achilles Therapeutics plc | 4.61 Million USD | -6199.675% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2873.307% |
| 180 Life Sciences Corp. | 1.32 Million USD | -21923.849% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1602.154% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -18596.463% |
| Nutriband Inc. | 241.28 Thousand USD | -120392.364% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2746.666% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -35097.337% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 22.207% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -865.912% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -7762.102% |
| Palisade Bio, Inc. | 369 Thousand USD | -78688.618% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -69955.422% |
| Beam Therapeutics Inc. | 173.17 Million USD | -67.884% |
| Neurogene Inc. | 16.25 Million USD | -1688.557% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 5.651% |
| AEON Biopharma, Inc. | 278 Thousand USD | -104479.137% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -86685.075% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -271887.352% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -283.235% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -375.772% |
| Athira Pharma, Inc. | 1.58 Million USD | -18242.587% |
| Vaccinex, Inc. | 247 Thousand USD | -117604.453% |
| HCW Biologics Inc. | 6.45 Million USD | -4406.2% |
| XOMA Corporation | 124.45 Million USD | -133.612% |
| Nektar Therapeutics | 230.4 Million USD | -26.184% |
| Arvinas, Inc. | 3.4 Million USD | -8450.882% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -17717.341% |
| Merus N.V. | 12.16 Million USD | -2290.479% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -126.376% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2004.604% |
| Rezolute, Inc. | 2.22 Million USD | -12948.923% |
| Clene Inc. | 32.16 Million USD | -803.983% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -165981.13% |
| BeyondSpring Inc. | 3.99 Million USD | -7177.347% |
| Synlogic, Inc. | 17.27 Million USD | -1582.952% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -22263.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -830557.143% |
| Peak Bio, Inc. | 10.72 Million USD | -2611.577% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -459.925% |
| Krystal Biotech, Inc. | 8.09 Million USD | -3491.92% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -64.239% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -4019.739% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -212742.438% |
| MannKind Corporation | 382.37 Million USD | 23.968% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2607.487% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -70983.13% |
| Gossamer Bio, Inc. | 212.46 Million USD | -36.837% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -166986.207% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3073.562% |
| Legend Biotech Corporation | 328.67 Million USD | 11.544% |
| Mural Oncology plc | 15 Million USD | -1837.038% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -513.018% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -13737.696% |
| Champions Oncology, Inc. | 7.43 Million USD | -3812.921% |
| REGENXBIO Inc. | 89.29 Million USD | -225.602% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -33915.563% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -52474.948% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -5269.967% |
| Vaxart, Inc. | 26.51 Million USD | -996.515% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1756.826% |
| Cellectis S.A. | 92.85 Million USD | -213.108% |
| Longeveron Inc. | 2.04 Million USD | -14144.488% |
| Repare Therapeutics Inc. | 3.41 Million USD | -8425.806% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 79.186% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -523.991% |
| Revolution Medicines, Inc. | 87.94 Million USD | -230.585% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -167952.023% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -7254.667% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -91612.934% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -166031.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 64.036% |
| Denali Therapeutics Inc. | 52.24 Million USD | -456.517% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1918.193% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -21059.389% |
| Cingulate Inc. | 3.13 Million USD | -9173.391% |
| Passage Bio, Inc. | 26.29 Million USD | -1005.69% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -4262.041% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -71157.353% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -32420.134% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1313.988% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -22973.81% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -11761.104% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -9209.318% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -35748.335% |
| OmniAb, Inc. | 25.56 Million USD | -1037.397% |
| Anew Medical, Inc. | 1.6 Million USD | -18014.019% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -882.765% |
| Lipocine Inc. | 17.16 Thousand USD | -1693538.588% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2398.11% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -739.581% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -4821.739% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -408.509% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -143116.749% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -5528.848% |
| Ocugen, Inc. | 6.94 Million USD | -4088.59% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1957.683% |
| Q32 Bio Inc. | 1.31 Million USD | -21958.422% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -43163.393% |
| Alumis Inc. Common Stock | 32.58 Million USD | -792.357% |
| Equillium, Inc. | 824 Thousand USD | -35182.767% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -3102.225% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -96550.333% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -90.894% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -468.52% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -37411.225% |
| Dominari Holdings Inc. | 3.02 Million USD | -9501.387% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -307593.122% |
| vTv Therapeutics Inc. | 529 Thousand USD | -54858.412% |
| Bio-Techne Corporation | 419.53 Million USD | 30.702% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -303.814% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -50.197% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1621.518% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1177.26% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -4699.109% |
| Nkarta, Inc. | 88.33 Million USD | -229.107% |
| BioCardia, Inc. | 1.31 Million USD | -22008.745% |
| Iterum Therapeutics plc | 19.5 Million USD | -1390.235% |